Will U.S. try to circumvent drug firms patent?

Will U.S. try to circumvent drug firms patent?
:
The furor over Abbott Laboratories’ 400 percent price increase last December of the AIDS drug Norvir has resulted in an unprecedented meeting at the National Institutes of Health to consider circumventing the drug giant’s patent.

Click here for reuse options!
Copyright 2004 Biotechblog

Leave a Reply

%d bloggers like this: